Open access
Aug 2026
Predictors of subsequent relapse-independent progression after high-efficacy therapy in relapsing multiple sclerosis
Background and objectives Progression independent of relapse activity (PIRA) is increasingly recognized as a major driver of disability accumulation in multiple sclerosis (MS). However, the factors associated with PIRA occurring after initiation of high-efficacy therapies (HETs) remain poorly investigated. We aimed to...
M. Foschi, A. Surcinelli, I. Panzera et al.
· Frontiers in Immunology · 0 citations